Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolai Loft

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|July 27, 2021
Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional studyNikolai Loft, Thao Thi Nguyen, Lars Erik Kristensen, et al.
JAAD International|December 24, 2024
Risk of infections during treatment with oral Janus kinase inhibitors in randomized placebo-controlled trials: A systematic review and meta-analysisDaniel Isufi, Mikkel Bak Jensen, Nikolai Loft, et al.
Clinical and Experimental Medicine|June 25, 2025
Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysisDaniel Isufi, Christopher Willy Schwarz, Mikkel Bak Jensen, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysisAnne-Sofie Halling, Nikolai Loft, Jonathan I Silverberg, et al.
Dermatology (Basel, Switzerland)|August 10, 2025
No Change in HbA1c Levels During Treatment with Biologics or Methotrexate in Patients with PsoriasisMaheen Fatima Bukhari, Christopher Willy Schwarz, Claus Otto Carl Zachariae, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 20, 2024
Characteristics of Patients With Psoriasis Treated With Various Biologics - A Danish Cohort StudyChristopher Willy Schwarz, Lone Skov, Alexander Egeberg, et al.
JAMA Dermatology|June 1, 2022
Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab: A Case SeriesChristian Enevold, Nikolai Loft, Anne Bregnhøj, et al.
The Journal of Dermatology|August 27, 2024
HLA-C*06:02 in Danish patients with psoriasis and response to biological treatmentMie Siewertsen Bergmann, Nikolai Loft, Christopher Willy Schwarz, et al.
Dermatologic Therapy|December 25, 2021
Impact of methotrexate and adalimumab on immune function of patients with psoriasisTanja Todberg, Nikolai Loft, Dina Leth Møller, et al.
International Journal of Molecular Sciences|June 19, 2024
The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisRownaq Fares Al-Sofi, Mie Siewertsen Bergmann, Claus Henrik Nielsen, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|July 27, 2021
Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional studyNikolai Loft, Thao Thi Nguyen, Lars Erik Kristensen, et al.
JAAD International|December 24, 2024
Risk of infections during treatment with oral Janus kinase inhibitors in randomized placebo-controlled trials: A systematic review and meta-analysisDaniel Isufi, Mikkel Bak Jensen, Nikolai Loft, et al.
Clinical and Experimental Medicine|June 25, 2025
Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysisDaniel Isufi, Christopher Willy Schwarz, Mikkel Bak Jensen, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysisAnne-Sofie Halling, Nikolai Loft, Jonathan I Silverberg, et al.
Dermatology (Basel, Switzerland)|August 10, 2025
No Change in HbA1c Levels During Treatment with Biologics or Methotrexate in Patients with PsoriasisMaheen Fatima Bukhari, Christopher Willy Schwarz, Claus Otto Carl Zachariae, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 20, 2024
Characteristics of Patients With Psoriasis Treated With Various Biologics - A Danish Cohort StudyChristopher Willy Schwarz, Lone Skov, Alexander Egeberg, et al.
JAMA Dermatology|June 1, 2022
Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab: A Case SeriesChristian Enevold, Nikolai Loft, Anne Bregnhøj, et al.
The Journal of Dermatology|August 27, 2024
HLA-C*06:02 in Danish patients with psoriasis and response to biological treatmentMie Siewertsen Bergmann, Nikolai Loft, Christopher Willy Schwarz, et al.
Dermatologic Therapy|December 25, 2021
Impact of methotrexate and adalimumab on immune function of patients with psoriasisTanja Todberg, Nikolai Loft, Dina Leth Møller, et al.
International Journal of Molecular Sciences|June 19, 2024
The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisRownaq Fares Al-Sofi, Mie Siewertsen Bergmann, Claus Henrik Nielsen, et al.
Pageof 4